SOLASTA Bio raised €13M in a Series A round in Sep 2024. The company is based in Glasgow, UK. Investors in the round: Corteva, FMC Ventures, Forbion. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
